Search for: "Watson Laboratories Inc."
Results 81 - 100
of 177
Sort by Relevance
|
Sort by Date
5 Aug 2012, 7:54 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc. [read post]
12 Jul 2012, 7:57 am
(“Solvay”), agreed to make over $20 million annual payments to the generic challengers Watson Pharmaceuticals, Inc., Par Pharmaceuticals, Inc., and Paddock Laboratories, Inc. [read post]
26 Apr 2012, 9:18 pm
Watson Laboratories Inc. [read post]
25 Apr 2012, 1:56 pm
Watson Pharmaceuticals, Inc., No. 10-12729, is available here. [read post]
25 Apr 2012, 9:05 am
The owners of the three approved ANDAs for generic oral vancomycin—Akorn, Incorporated (“Akorn”), Watson Laboratories, Inc. [read post]
18 Apr 2012, 8:15 pm
Watson Pharmaceuticals, Inc., et al. 1:12-cv-00321; filed March 30, 2012 in the Middle District of North Carolina • Plaintiffs: Allergan, Inc.; Duke University • Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
10 Apr 2012, 1:15 pm
The Loryna and Syeda OCs are made and sold by Sandoz, Inc. [read post]
3 Apr 2012, 9:15 am
Watson Laboratories, Inc. [read post]
27 Mar 2012, 8:51 am
Watson Laboratories, Inc., C.A. [read post]
7 Mar 2012, 4:54 am
., filed a patent infringement action against Watson Laboratory, Inc. [read post]
19 Feb 2012, 8:55 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories Inc. [read post]
13 Feb 2012, 12:54 pm
Watson Laboratories, Inc., C.A. [read post]
4 Dec 2011, 8:52 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Laboratories, Inc. [read post]
1 Dec 2011, 2:02 pm
(NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Vestura(TM) (3 mg drospirenone and 0.02 mg ethinyl estradiol), a generic version of Bayer's Yaz(R) oral contraceptive product. [read post]
1 Nov 2011, 6:08 am
Inc. have experienced problems. [read post]
10 Oct 2011, 10:00 am
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
9 Oct 2011, 9:37 pm
• Defendants: Watson Pharmaceuticals Inc.; Watson Laboratories Inc.; Watson Pharma Inc.; Watson Laboratories Inc. - Florida Infringement of U.S. [read post]
30 Sep 2011, 2:32 pm
Barr Laboratories, Inc., 386 F.3d 485, 485 (2d Cir. 2004) [read post]
27 Jul 2011, 1:01 am
Paddock Laboratories, Inc. [read post]
20 Jul 2011, 4:04 am
: Supreme Court hearing Human Genome Sciences Inc v Eli Lilly and Company (IPKat) Nexium (Esomeprazole) – UK: EWHC: Ranbaxy wins declaration of non-infringement: Ranbaxy v AstraZeneca (IPKat) Olanzapine – Spain: Supreme Court hands down landmark judgment on doctrine of equivalents and TRIPS (Kluwer Patent Blog) OxyContin (Oxycodone) – US: Purdue files patent infringement suit against Sandoz in response to Para IV certification (Patent Docs) Prevacid (Lansoprazole) –… [read post]
